Inovio Halts Head And Neck Cancer Trial On Safety Concerns
This article was originally published in The Pink Sheet Daily
Firm prematurely stopped a pivotal oncology study investigating its tumor ablation technology after an independent data monitoring committee raised concerns about adverse events.
You may also be interested in...
Electroporation-focused Inovio finds an “amazing” fit, CEO says.
The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.